SSKN logo

STRATA Skin Sciences (SSKN)

Profile

Full Name

STRATA Skin Sciences, Inc.

Ticker Symbol

SSKN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

November 3, 2005

Indexes

Not included

Website

http://www.strataskinsciences.com

Employees

106

Key Details

Price

$2.63(-2.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$33.56M(+0.61% YoY)

Annual EPS

-$2.65(+14.52% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.63
SSKN price is $2.63

30-Day Relative Volume

1.46
SSKN 30-day relative volume is 1.46

Price Performance

Price Most recent change

-2.59%
SSKN price was down -2.59% on May 2, 2025

Price YTD change

-9.62%
SSKN price is down -9.62% since January 1st

Price 1-year change

-34.25%
SSKN price is down -34.25% year-on-year

Price 3-year change

-79.13%
SSKN price is down -79.13% over the past 3 years

Price Range

Price All-time high

$6120.00
SSKN price is currently -99.96% below its historical high of $6120.00

Price 3-year low

$2.51
SSKN price is currently +4.78% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$10.97M
SSKN market capitalization is $10.97 million

Market cap 3-year change

-74.93%
SSKN market capitalization is down -74.93% over the past 3 years

Market cap All-time high

$260.82M
SSKN market capitalization is currently -95.79% below its historical high of $260.82 million

Market cap sector rank

18.57%
SSKN market capitalization is higher than 18.57% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+18.97%
SSKN shares outstanding is up +18.97% year-on-year

Shares Outstanding 3-Year Change

+20.13%
SSKN shares outstanding is up +20.13% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.22
SSKN beta is 0.22

200-day SMA

$2.92
SSKN price is currently -9.96% below its 200-day simple moving average

50-day SMA

$2.64
SSKN price is currently -0.46% below its 50-day simple moving average

RSI

50.88
SSKN 14-day relative strength index is 50.88

Volume

1.46
SSKN 30-day relative volume is 1.46

ATR

$0.08
SSKN average true range is $0.08

10-day Historical Volatility

51.86%
SSKN 10-day historical volatility is 51.86%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$33.56M
SSKN annual revenue is $33.56 million

Revenue Analysts estimate

$35.45M
SSKN annual revenue is currently -5.33% lower than the consensus analysts' forecast

Revenue 1-year change

+0.61%
SSKN annual revenue is up +0.61% year-on-year

Revenue Sector rank

41.22%
SSKN annual revenue is higher than 41.22% of companies in Healthcare sector

EPS

EPS

-$2.65
SSKN annual earnings per share is -$2.65

EPS Analysts estimate

-$1.15
SSKN annual earnings per share is currently +130.43% higher than the consensus analysts' forecast

EPS 1-year change

+14.52%
SSKN annual earnings per share is up +14.52% year-on-year

EPS Sector rank

32.48%
SSKN annual earnings per share is higher than 32.48% of companies in Healthcare sector

Profit

Gross profit

$19.08M
SSKN annual gross profit is $19.08 million

Gross margin

56.85%
SSKN annual gross profit margin is 56.85%

Operating profit

-$5.39M
SSKN annual operating income is -$5.39 million

Operating margin

-16.07%
SSKN annual operating profit margin is -16.07%

Net income

-$10.09M
SSKN annual net profit is -$10.09 million

Net margin

-30.05%
SSKN annual net profit margin is -30.05%

Expenses

Total expenses

$38.96M
SSKN annual total expenses is $38.96 million

Operating expenses

$24.48M
SSKN annual total operating expenses is $24.48 million

Cost of goods sold

$14.48M
SSKN annual cost of goods sold is $14.48 million

Selling, general & administrative expenses

$23.59M
SSKN annual SGA is $23.59 million

Depreciation and amortization

$5.31M
SSKN annual depreciation & amortization is $5.31 million

Interest expense

$2.11M
SSKN annual interest expense is $2.11 million

Income tax

-$170.00K
SSKN annual income tax is -$170.00 thousand

EBIT & EBITDA

EBIT

-$8.15M
SSKN annual earnings before interest & taxes is -$8.15 million

EBITDA

-$2.84M
SSKN annual EBITDA is -$2.84 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$36.16M
SSKN annual total assets is $36.16 million

Non current assets

$19.56M
SSKN annual long term assets is $19.56 million

Current assets

$16.59M
SSKN annual total current assets is $16.59 million

Cash and cash equivalents

$7.26M
SSKN annual cash & cash equivalents is $7.26 million

Accounts receivable

$5.25M
SSKN annual accounts receivable is $5.25 million

Inventory

$2.25M
SSKN annual inventory is $2.25 million

Liabilities

Total liabilities

$31.18M
SSKN annual total liabilities is $31.18 million

Long term liabilities

$16.56M
SSKN annual total long term liabilities is $16.56 million

Current liabilities

$14.63M
SSKN annual total current liabilities is $14.63 million

Accounts payable

$2.43M
SSKN annual accounts payable is $2.43 million

Debt

Total debt

$16.44M
SSKN annual total debt is $16.44 million

Total debt 1-year change

+5.16%
SSKN annual total debt is up +5.16% year-on-year

Long term debt

$16.11M
SSKN annual long term debt is $16.11 million

Short term debt

$328.00K
SSKN annual short term debt is $328.00 thousand

Equity & Capital

Shareholders equity

$4.97M
SSKN annual stockholders equity is $4.97 million

Book value

$4.97M
SSKN annual book value is $4.97 million

Retained earnings

-$248.14M
SSKN annual retained earnings is -$248.14 million

Working capital

$1.97M
SSKN annual working capital is $1.97 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$188.00K
SSKN annual cash flow from operations is $188.00 thousand

Cash from operations 1-year change

+136.22%
SSKN annual cash flow from operations is up +136.22% year-on-year

Cash from investing

-$1.64M
SSKN annual cash flow from investing activities is -$1.64 million

Cash from investing 1-year change

+67.4%
SSKN annual cash flow from investing activities is up +67.4% year-on-year

Cash from financing

$1.93M
SSKN annual cash flow from financing activities is $1.93 million

Cash from financing 1-year change

-71.94%
SSKN annual cash flow from financing activities is down -71.94% year-on-year

CAPEX

CAPEX

$1.64M
SSKN annual capital expenditures is $1.64 million

CAPEX 1-year change

-67.4%
SSKN annual capital expenditures is down -67.4% year-on-year

Free Cash Flow

Free cash flow

-$1.45M
SSKN annual free cash flow is -$1.45 million

Free cash flow 1-year change

+73.85%
SSKN annual free cash flow is up +73.85% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

56.85%
SSKN annual gross profit margin is 56.85%

Operating margin

-16.07%
SSKN annual operating profit margin is -16.07%

Net margin

-30.05%
SSKN annual net profit margin is -30.05%

ROA & ROE

ROA

-25.80%
SSKN annual return on assets is -25.80%

ROE

-114.22%
SSKN annual return on equity is -114.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SSKN price to earnings ratio value is unknown

PE ratio Sector rank

-
SSKN price to earnings ratio is unknown

PB Ratio

PB ratio

2.21
SSKN price to book ratio is 2.21

PB ratio Sector rank

61.98%
SSKN price to book ratio is higher than 61.98% of companies in Healthcare sector

PS Ratio

PS ratio

0.33
SSKN price to sales ratio is 0.33

PS ratio Sector rank

9.46%
SSKN price to sales ratio is higher than 9.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$20.15M
SSKN enterprise value is $20.15 million

Enterprise value Sector rank

30.87%
SSKN enterprise value is higher than 30.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.09
SSKN EV/EBITDA is -7.09

EV/EBITDA Sector rank

16.39%
SSKN EV/EBITDA is higher than 16.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.13
SSKN annual current ratio is 1.13

Quick ratio

0.98
SSKN annual quick ratio is 0.98

Leverage

Debt to equity

3.06
SSKN annual debt to equity ratio is 3.06

Interest coverage ratio

-3.87
SSKN annual interest coverage ratio is -3.87

Risk & Stability

Piotroski F-Score

4
SSKN piotroski f-score is 4

Altman Z-Score

-9.15
SSKN altman z-score is -9.15

Analyst ratings

Recent major analysts updates

Feb 27, 25 Maxim Group
Buy
May 16, 23 CG Capital
Outperform
Nov 3, 20 HC Wainwright & Co.
Buy
Mar 17, 20 HC Wainwright & Co.
Neutral
Dec 9, 19 Ladenburg Thalmann
Buy
Nov 21, 19 Oppenheimer
Outperform
Dec 10, 18 Northland Securities
Outperform
Dec 10, 18 Northland Capital Markets
Outperform

Institutional Ownership

Similar stocks

IMRN logo
Immuron Limited (IMRN)
Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
PRPO logo
Precipio (PRPO)
PSTV logo
Plus Therapeutics (PSTV)
TLPH logo
Talphera (TLPH)
MRAI logo
Marpai (MRAI)
ATHA logo
Athira Pharma (ATHA)
SNSE logo
Sensei Biotherapeutics (SNSE)
ERNA logo
Eterna Therapeutics (ERNA)
  • What is the ticker symbol for STRATA Skin Sciences?
  • Does STRATA Skin Sciences pay dividends?
  • What sector is STRATA Skin Sciences in?
  • What industry is STRATA Skin Sciences in?
  • What country is STRATA Skin Sciences based in?
  • When did STRATA Skin Sciences go public?
  • Is STRATA Skin Sciences in the S&P 500?
  • Is STRATA Skin Sciences in the NASDAQ 100?
  • Is STRATA Skin Sciences in the Dow Jones?
  • When was STRATA Skin Sciences's last earnings report?
  • When does STRATA Skin Sciences report earnings?
  • Should I buy STRATA Skin Sciences stock now?

What is the ticker symbol for STRATA Skin Sciences?

The ticker symbol for STRATA Skin Sciences is NASDAQ:SSKN

Does STRATA Skin Sciences pay dividends?

No, STRATA Skin Sciences does not pay dividends

What sector is STRATA Skin Sciences in?

STRATA Skin Sciences is in the Healthcare sector

What industry is STRATA Skin Sciences in?

STRATA Skin Sciences is in the Medical Devices industry

What country is STRATA Skin Sciences based in?

STRATA Skin Sciences is headquartered in United States

When did STRATA Skin Sciences go public?

STRATA Skin Sciences's initial public offering (IPO) was on November 3, 2005

Is STRATA Skin Sciences in the S&P 500?

No, STRATA Skin Sciences is not included in the S&P 500 index

Is STRATA Skin Sciences in the NASDAQ 100?

No, STRATA Skin Sciences is not included in the NASDAQ 100 index

Is STRATA Skin Sciences in the Dow Jones?

No, STRATA Skin Sciences is not included in the Dow Jones index

When was STRATA Skin Sciences's last earnings report?

STRATA Skin Sciences's most recent earnings report was on Mar 27, 2025

When does STRATA Skin Sciences report earnings?

The next expected earnings date for STRATA Skin Sciences is May 15, 2025

Should I buy STRATA Skin Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page